Analyst Ratings for Ultragenyx Pharma (RARE)
RARE Rating Summary
RARE Price Target Summary
- Highest: $77.00 (Jefferies)
- Lowest: $16.00 (Baird)
- Average: $34.06
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$34.06 (+136.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$34.06 (+136.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Morgan Stanley | Maxwell Skor | Downgrade | Equalweight (Overweight) |
18.00 (74.00) |
26.53 (14.40) |
-45.72% | Details |
| 9/3/2026 | BofA Securities | Tazeen Ahmad | Downgrade | Neutral (Buy) |
20.00 (48.00) |
26.53 (14.40) |
-45.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
